Compare BWMN & OVID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BWMN | OVID |
|---|---|---|
| Founded | 1995 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Military/Government/Technical | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 572.9M | 522.6M |
| IPO Year | 2021 | 2017 |
| Metric | BWMN | OVID |
|---|---|---|
| Price | $31.21 | $2.22 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 5 |
| Target Price | ★ $45.50 | $4.60 |
| AVG Volume (30 Days) | 94.5K | ★ 1.4M |
| Earning Date | 05-05-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 329.41 | 3.90 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $490,017,000.00 | $7,252,000.00 |
| Revenue This Year | $14.93 | N/A |
| Revenue Next Year | $11.57 | $19.34 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 14.88 | ★ 1181.27 |
| 52 Week Low | $25.96 | $0.27 |
| 52 Week High | $45.83 | $3.11 |
| Indicator | BWMN | OVID |
|---|---|---|
| Relative Strength Index (RSI) | 46.23 | 36.66 |
| Support Level | $30.52 | $1.95 |
| Resistance Level | $36.86 | $2.38 |
| Average True Range (ATR) | 1.15 | 0.17 |
| MACD | -0.13 | -0.03 |
| Stochastic Oscillator | 31.44 | 9.01 |
Bowman Consulting Group Ltd is a professional services firm delivering engineering solutions to customers who own, develop, and maintain the built environment. It provides planning, engineering, construction management, commissioning, environmental consulting, geospatial, survey, land procurement, and other technical services to customers operating in a diverse set of end markets. Its services include Civil & Site Engineering, Transportation Engineering, MEP Engineering, Commissioning & Energy Efficiency, Energy Services, Water/Wastewater, Fire Protection, Construction Management, Survey/Geospatial, Environmental Consulting, Structural Engineering, Land Procurement & Right-of-Way, Landscape and Architecture/Planning.
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.